A small study in 2018 demonstrated that using pharmacogenomic testing to help select antidepressants led to better treatment rates.
Pharmacogenomic testing and major depressive disorder
Updated: Jul 15, 2022
top of page
bottom of page
Updated: Jul 15, 2022
A small study in 2018 demonstrated that using pharmacogenomic testing to help select antidepressants led to better treatment rates.
Comments